microdosing glp-1 for maintenance vs. Maintenance, Unpacked by Experts Go Into Maintenance WITHOUT Rebounding

Micronutrient and nutritional deficiencies associated with GLP-1 receptor agonist therapy: a narrative review

2023;14 doi: 10.3389/FENDO.2023.1214334

Until the NDA clears in 2027 (best case), the only access route for self-experimenters is the research-peptide market

Pham P, Sarkar M, Pham P, Pham P

Numerous reports also emphasize the neuroprotective role of GLP-1 mediated signaling, as it was proven to protect synapses, improve synaptic functions, enhance neurogenesis, protect neurons from oxidative stress, and reduce neuronal apoptosis

Major Pharmaceutical Manufacturers and Their GLP-1 Portfolios Novo Nordisk leads the GLP-1 market with semaglutide products: Ozempic (diabetes), Wegovy (weight management), and Rybelsus (oral form)